Larvol Delta - LETERCOR-Efficacy-of-Letermovir-in-Preventing-Cytomegalovirus-CMV-Infection-in-Lung-Transplant-Recipients-vs-Valganciclovir

Valcyte (valganciclovir) - Roche, Tanabe Pharma

Prevymis (letermovir) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT06057194

Mar 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next